Control of extensively drug-resistant Pseudomonas aeruginosa co-harboring metallo-β-lactamase enzymes with oprD gene downregulation

被引:1
|
作者
El-Sherbiny, Gamal M. [1 ]
Basha, Amr Mohamad [2 ]
Mabrouk, Mona, I [2 ]
机构
[1] Al Azhar Univ, Fac Sci Boys, Dept Bot & Microbiol, Cairo, Egypt
[2] Egyptian Drug Author, Dept Microbiol, Natl Org Drug Control & Res, Giza, Egypt
关键词
Combinations; Treatment; XDR- Pseudomonas aeruginosa; Control of (XDR-CR Pseudomonas aeruginosa; SYNERGISTIC ACTIVITIES; COMBINATION; MECHANISMS; COLISTIN; IMIPENEM; RIFAMPICIN; STRAINS;
D O I
10.1016/j.ijmmb.2021.11.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Purpose: to study control and treatment of infection with extensive drug-resistant carbapenem-resistant Pseudomonas aeruginosa (XDR-CRPA). Methods: Eleven Pseudomonas aeruginosa (XDR-CRPA) strains used in this study were isolated from a clinical sample, identified, and antibiotics susceptibility recorded in a previous study. Real-time PCR (RT-PCR) was performed to determine the expression level of the OprD gene. Besides, a checkerboard technique was performed to assess the effect of polymyxin-B (PDX), colistin (COL), rifampicin (RIF), imipenem (IPM), and meropenem (MEM) during 2 and 3- dimensional antibiotic combinations. Further, the time-kill study was determined for the most potent combination against four representative strains, log io changes of viable cell counts were expressed as their mean value (+/- SD) values. Results: Molecular analysis by Real-time PCR revealed that the diminished expression level of OprD mRNA was overwhelming to various degrees. The checkerboard method demonstrated that the relevant synergism was achieved in 90.9% of strains for both carbapenem antibiotics during the triple combinations. While an additive effect was noted for all the dual regimen assays. Regarding time-kill experiments, a remarkable bactericidal effect with [99.9% killing rate] was observed toward only one strain whilst a bacteriostatic attitude was proven with >= 95% bacterial eradication against the three remaining strains. Conclusions: These findings underscore the promising implications of these combinations for treatment against XDR-Pseudomonas aeruginosa even they are resistant to carbapenems due to multiple mechanisms of action.
引用
收藏
页码:51 / 56
页数:6
相关论文
共 50 条
  • [41] Analysis of integrons and associated gene cassettes of metallo-β-lactamase-positive Pseudomonas aeruginosa in Malaysia
    Khosravi, Yalda
    Tay, Sun Tee
    Vadivelu, Jamuna
    JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 60 (07) : 988 - 994
  • [42] Molecular characterization of extensively drug-resistant hypervirulent Pseudomonas aeruginosa isolates in China
    Li, Jun
    Tang, Mengli
    Liu, Zhaojun
    Wei, Yuhan
    Xia, Fengjun
    Xia, Yubing
    Hu, Yongmei
    Wang, Haichen
    Zou, Mingxiang
    ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2024, 23 (01)
  • [43] Extensively drug-resistant Pseudomonas aeruginosa panophthalmitis from contaminated artificial tears
    Wang, Taylor
    Jain, Sumeet
    Glidai, Yoav
    Dua, Prachi
    Dempsey, Katharine S.
    Shakin, Eric
    Chu, David S.
    Epstein, Marcia
    Ha, Lawrence G.
    IDCASES, 2023, 33
  • [44] Active monotherapy and combination therapy for extensively drug-resistant Pseudomonas aeruginosa pneumonia
    Khawcharoenporn, Thana
    Chuncharunee, Alan
    Maluangnon, Chailat
    Taweesakulvashra, Thitiporn
    Tiamsak, Pimsiri
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 52 (06) : 828 - 834
  • [45] Phylogenetic study of metallo-β-lactamase producing multidrug resistant Pseudomonas aeruginosa isolates from burn patients
    Jena, Jayanti
    Debata, Nagen Kumar
    Sahoo, Rajesh Kumar
    Subudhi, Enketeswara
    BURNS, 2015, 41 (08) : 1758 - 1763
  • [46] Imipenem-resistant Pseudomonas aeruginosa strains carry metallo-β-lactamase gene blaVIM in a level I Iranian burn hospital
    Bahar, Mohammad Ali
    Jamali, Shohreh
    Samadikuchaksaraei, Ali
    BURNS, 2010, 36 (06) : 826 - 830
  • [47] Characterization of AmpC β-lactamase mutations of extensively drug-resistant Pseudomonas aeruginosa isolates that develop resistance to ceftolozane/tazobactam during therapy
    Fernandez-Esgueva, Marta
    Isabel Lopez-Calleja, Ana
    Mulet, Xavier
    Fraile-Ribot, Pablo A.
    Cabot, Gabriel
    Huarte, Rafael
    Rezusta, Antonio
    Oliver, Antonio
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2020, 38 (10): : 474 - 478
  • [48] New Delhi metallo-β-lactamases among extensively drug-resistant clinical isolates from Lahore, Pakistan
    Ul Ain, Noor
    Hannan, Abdul
    Imran, Namrah
    Ali, Asad
    Rasheed, Farhan
    Sultan, Sikander
    McHugh, Timothy D.
    Riaz, Saba
    FUTURE MICROBIOLOGY, 2024, 19 (11) : 971 - 981
  • [49] Dissemination of High-Risk Clones of Extensively Drug-Resistant Pseudomonas aeruginosa in Colombia
    Correa, Adriana
    del Campo, Rosa
    Perenguez, Marcela
    Blanco, Victor M.
    Rodriguez-Banos, Mercedes
    Perez, Federico
    Maya, Juan J.
    Rojas, Laura
    Canton, Rafael
    Arias, Cesar A.
    Villegas, Maria V.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) : 2421 - 2425
  • [50] Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis
    Funiciello, Elisa
    Mula, Jacopo
    Mignone, Federica
    Silvestro, Erika
    Ragazzi, Paola
    Pilloni, Giulia
    Costa, Cristina
    D'Avolio, Antonio
    Garazzino, Silvia
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (11) : 2776 - 2778